Q4 2023 13F Holders as of 31 Dec 2023
-
Type / Class
-
Equity / Common Stock, $0.0001 par value per share
-
Shares outstanding
-
22,766,960
-
Total 13F shares
-
19,769,303
-
Share change
-
+2,289,220
-
Total reported value
-
$4,574,587,850
-
Put/Call ratio
-
31%
-
Price per share
-
$231.38
-
Number of holders
-
225
-
Value change
-
+$602,581,939
-
Number of buys
-
130
-
Number of sells
-
93
Institutional Holders of MADRIGAL PHARMACEUTICALS, INC. - Common Stock, $0.0001 par value per share (MDGL) as of Q4 2023
As of 31 Dec 2023,
MADRIGAL PHARMACEUTICALS, INC. - Common Stock, $0.0001 par value per share (MDGL) was held by
225 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
19,769,303 shares.
The largest 10 holders included
JANUS HENDERSON GROUP PLC, BAKER BROS. ADVISORS LP, Avoro Capital Advisors LLC, VANGUARD GROUP INC, BlackRock Inc., PAULSON & CO. INC., RTW INVESTMENTS, LP, STATE STREET CORP, FMR LLC, and PRICE T ROWE ASSOCIATES INC /MD/.
This page lists
225
institutional shareholders reporting positions in this security
for the Q4 2023 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.